Skip to content

Merck IISP Stewardship Grant for Antibiotic Best Practices

Implementation of Antimicrobial Stewardship and Decision Support Into the EPIC Electronic Medical Record

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01573195
Enrollment
1285
Registered
2012-04-06
Start date
2011-03-31
Completion date
2012-04-30
Last updated
2014-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Antibiotic Resistant Infection

Keywords

deescalation, best practice alert, antimicrobial stewardship

Brief summary

The purpose of this study is to pilot the use of best practices alerts to enhance an antimicrobial stewardship program using the electronic medical record, EPIC.

Detailed description

The purpose of this study is to pilot the use of best practices to enhance an antimicrobial stewardship program using the electronic medical record, EPIC. Screening information technology tools via SETNET/Safety SUrveyor(Premier) and the electronic anti-infective order form would allow for sufficient medical record review to create best practices alerts for the purpose of appropriate de-escalation of anti-invectives.

Interventions

None listed

Sponsors

University of Wisconsin, Madison
Lead SponsorOTHER

Study design

Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Physicians with prescribing privileges at the UWHC

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
Percentage of best practice alerts(BPA) that were completely accepted, partially accepted, or rejected within 72 hours of issuing the BPAOne Yearafter issuing the BPA for deescalation, the responding healthcare provider will respond in one of the manners above

Secondary

MeasureTime frameDescription
The number and type of antiinfectives that were administered before and after(11days) the best practice alert is issued.One yearThe antiinfective use before and after the BPA will be analyzed in detail. The number of antibiotics, percentage decrease(or less likely increase) in antiinfectives in the 3 days before BPA , and 11 days after the BPA will be analyzed. A cost analysis will be performed. Patient outcomes will not be assessed.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026